Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation

The financing will further scale BillionToOne’s prenatal screening and oncology diagnostics businesses MENLO PARK, Calif., June 21, 2024 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company, announced today that it has raised $130 million in an oversubscribed,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks